Immunogenic chemotherapy effectively inhibits KRAS-Driven lung cancer
Author:
Funder
key project of the National Natural Science Foundation of China
Strategic Priority Research Program of the Chinese Academy of Sciences
CAS
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference49 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J. Clin.,2018
2. Comprehensive molecular profiling of lung adenocarcinoma;Cancer Genome Atlas Research Network;Nature,2014
3. The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome;Remark;Am. J. Respir. Crit. Care Med.,2015
4. Clinical implications of genomic discoveries in lung cancer;Swanton;N. Engl. J. Med.,2016
5. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib;Kobayashi;N. Engl. J. Med.,2005
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Current progress of immune checkpoint inhibitors for advanced colorectal cancer: concentrating on the efficacy improvement;Critical Reviews in Oncology/Hematology;2023-11
2. Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-09
3. Trial watch: chemotherapy-induced immunogenic cell death in oncology;OncoImmunology;2023-06-03
4. Promotion of ICD via Nanotechnology;Macromolecular Bioscience;2023-05-07
5. Tumor-secreted lactate contributes to an immunosuppressive microenvironment and affects CD8 T-cell infiltration in glioblastoma;Frontiers in Immunology;2023-04-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3